---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-22-029381"
form_type: "8-K"
ticker: "VXRT"
cik: "0000072444"
company_name: "Vaxart, Inc."
filed_at: "2022-12-19T23:59:59+00:00"
generated_at: "2026-06-21T02:56:34.182319+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Vaxart appoints Phillip Lee as CFO; interim CFO Fuad Ahmad steps down

## Summary
- Phillip Lee appointed CFO, Principal Accounting Officer, and Principal Financial Officer effective Dec 15, 2022.
- Lee previously CFO at Clover Biopharmaceuticals; brings ~15 years biotech finance experience.
- Lee receives $420K base salary, 40% target bonus, option for 412,500 shares, and 68,750 RSUs.
- Fuad Ahmad ceased as Interim CFO on same date.
- Press release issued Dec 19, 2022.

## SEC filing metadata
- accession: 0001437749-22-029381
- form_type: 8-K
- ticker: VXRT
- cik: 0000072444
- company_name: Vaxart, Inc.
- filed_at: 2022-12-19T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/72444/000143774922029381/0001437749-22-029381-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/72444/000143774922029381/vxrt20221219_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-22-029381
- JSON: https://secwatch.observer/filing/0001437749-22-029381.json
- Plain text: https://secwatch.observer/filing/0001437749-22-029381.txt

## Key facts
- Executive change
  Phillip E. Lee was appointed as Chief Financial Officer, Principal Accounting Officer, and Principal Financial Officer at Vaxart, Inc..
  - Action: appointed
  - Role: Chief Financial Officer, Principal Accounting Officer, and Principal Financial Officer
  source text: On December 15, 2022 (the “ Start Date ”), Vaxart, Inc. (the “ Company ”) appointed Phillip E. Lee as the Company’s Chief Financial Officer and as the Company’s Principal Accounting Officer and Principal Financial Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/72444/000143774922029381/0001437749-22-029381-index.htm
- Executive change
  Fuad Ahmad departed as Interim Chief Financial Officer, Principal Accounting Officer, and Principal Financial Officer at Vaxart, Inc..
  - Action: ceased
  - Role: Interim Chief Financial Officer, Principal Accounting Officer, and Principal Financial Officer
  source text: As of December 15, 2022, Fuad Ahmad ceased to serve as the Company’s Interim Chief Financial Officer, Principal Accounting Officer, and Principal Financial Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/72444/000143774922029381/0001437749-22-029381-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.